Depomed, Inc.
Get Full AccessDescription
- Depomed, Inc. is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions. Founded in 1995, Depomed has successfully executed on strategy of acquiring, integrating and growing differentiated therapeutic products and building each into a strong market presence. The result is a broad portfolio of pain and neurology specialty pharmaceuticals currently comprised of five FDA-approved products. These include Gralise® for the management of Postherpetic Neuralgia (PHN), Cambia® for the acute treatment of migraine attacks, Zipsor® for the relief of mild to moderate acute pain, Lazanda® for the management of breakthrough pain in cancer patients and our most recent addition, the companys flagship asset, the NUCYNTA® franchise.Acquired in April 2015 and re-launched in June 2015, the NUCYNTA franchise includes NUCYNTA® ER for the extended management of pain, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) and NUCYNTA® for immediate management of moderate to severe acute pain in adults. Depomed also has successfully developed and licensed its unique drug-delivery technology, Acuform®. This patented oral-delivery technology allows for the targeted, extended release of pharmaceutical compounds into the upper gastrointestinal tract. The companys Acuform technology is currently being used in four marketed drugs, including Gralise.Depomeds successful execution on strategy and has resulted in solid product revenue growth over the past three years. Located in Newark, California in the East Bay of San Francisco, Depomed is listed on the NASDAQ market under the ticker DEPO and employs approximately 500 people, of which approximately 350 are part of the Commercial organization.Depomed is an AA/EEO/Veterans/Disabled employer.
-
Headquarters:7999 Gateway Boulevard Suite 300, Newark, California, United States
More -
Phone Number: +1 510-744-3000
-
Website: https://www.depomed.com
-
Employees:278
-
Revenue:$50 - 100M
-
Legal Name:Depomed, Inc.
-
Depomed, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Depomed, Inc.
-
Where are Depomed, Inc.'s Headquarters?
Depomed, Inc.'s Headquarters are in 7999 Gateway Boulevard Suite 300,Newark,California,United States
-
What is Depomed, Inc.'s phone number?
Depomed, Inc.'s phone number is +1 510-744-3000
-
What is Depomed, Inc.'s official website?
Depomed, Inc.'s official website is https://www.depomed.com
-
What is Depomed, Inc.'s Revenue?
Depomed, Inc.'s revenue is $50 - 100M
-
What is Depomed, Inc.'s NAICS code?
Depomed, Inc.'s NAICS code is 325412
-
How many employees are working in Depomed, Inc.
Depomed, Inc. has 278 employees
-
What is Depomed, Inc.'s Industry?
Depomed, Inc. is in the industry of Pharmaceuticals
-
Who is Depomed, Inc.'s Vice President, Chief Compliance Officer?
Depomed, Inc.'s Vice President, Chief Compliance Officer is Jeff Carrol